Journal
PROGRESS IN RETINAL AND EYE RESEARCH
Volume 87, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.preteyeres.2021.100998
Keywords
Glia; Glaucoma; Immunomodulation; Neurodegeneration; Neuroinflammation; Retinal ganglion cell
Categories
Funding
- National Eye Institute [P3 0EY019007, R01EY028153]
- AR and JR Peacock Trusts
- Rees Scholarship
- Research to Prevent Blindness
- Homer McK
Ask authors/readers for more resources
Neuroinflammation plays a significant role in the neurodegenerative processes of glaucoma, with glial cells and peripheral immune cells causing toxicity to retinal ganglion cells. The interaction between glial cells and immune cells is crucial in amplifying neuroinflammation and determining the neurodegenerative outcome. Inhibition of neurodegenerative inflammation may provide a broad treatment strategy for rescuing retinal ganglion cell integrity and function, while targeting both inflammatory toxicity and mitochondrial dysfunction.
Neuroinflammation relying on the inflammatory responses of glial cells has emerged as an impactful component of the multifactorial etiology of neurodegeneration in glaucoma. It has become increasingly evident that despite early adaptive and reparative features of glial responses, prolonged reactivity of the resident glia, along with the peripheral immune cells, create widespread toxicity to retinal ganglion cell (RGC) axons, somas, and synapses. As much as the synchronized responses of astrocytes and microglia to glaucoma-related stress or neuron injury, their bi-directional interactions are critical to build and amplify neuroinflammation and to dictate the neurodegenerative outcome. Although distinct molecular programs regulate somatic and axonal degeneration in glaucoma, inhibition of neurodegenerative inflammation can provide a broadly beneficial treatment strategy to rescue RGC integrity and function. Since inflammatory toxicity and mitochondrial dysfunction are converging etiological paths that can boost each other and feed into a vicious cycle, anti-inflammatory treatments may also offer a multi-target potential. This review presents an overview of the current knowledge on neuroinflammation in glaucoma with particular emphasis on the cell-intrinsic and cell-extrinsic factors involved in the reciprocal regulation of glial responses, the interdependence between inflammatory and mitochondrial routes of neurodegeneration, and the research aspects inspiring for prospective immunomodulatory treatments. With the advent of powerful technologies, ongoing research on molecular and functional characteristics of glial responses is expected to accumulate more comprehensive and complementary information and to rapidly move the field forward to safe and effective modulation of the glial pro-inflammatory activities, while restoring or augmenting the glial immune-regulatory and neurosupport functions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available